[go: up one dir, main page]

SI1105391T1 - Imidazo(1,2-a)piridinske spojine, ki inhibirajo izločanje želodčne kisline, njihovi farmacevtski sestavki in postopki za njihovo pripravo - Google Patents

Imidazo(1,2-a)piridinske spojine, ki inhibirajo izločanje želodčne kisline, njihovi farmacevtski sestavki in postopki za njihovo pripravo

Info

Publication number
SI1105391T1
SI1105391T1 SI9930698T SI9930698T SI1105391T1 SI 1105391 T1 SI1105391 T1 SI 1105391T1 SI 9930698 T SI9930698 T SI 9930698T SI 9930698 T SI9930698 T SI 9930698T SI 1105391 T1 SI1105391 T1 SI 1105391T1
Authority
SI
Slovenia
Prior art keywords
imidazo
processes
pharmaceutical compositions
gastric acid
acid secretion
Prior art date
Application number
SI9930698T
Other languages
English (en)
Inventor
Kosrat Amin
Mikael Dahlstrm
Peter Nordberg
Ingemar Starke
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of SI1105391T1 publication Critical patent/SI1105391T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SI9930698T 1998-08-21 1999-08-18 Imidazo(1,2-a)piridinske spojine, ki inhibirajo izločanje želodčne kisline, njihovi farmacevtski sestavki in postopki za njihovo pripravo SI1105391T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9802794A SE9802794D0 (sv) 1998-08-21 1998-08-21 New compounds
PCT/SE1999/001402 WO2000011000A2 (en) 1998-08-21 1999-08-18 New compounds

Publications (1)

Publication Number Publication Date
SI1105391T1 true SI1105391T1 (sl) 2005-02-28

Family

ID=20412307

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930698T SI1105391T1 (sl) 1998-08-21 1999-08-18 Imidazo(1,2-a)piridinske spojine, ki inhibirajo izločanje želodčne kisline, njihovi farmacevtski sestavki in postopki za njihovo pripravo

Country Status (20)

Country Link
US (3) US6579884B1 (sl)
EP (2) EP1411056A3 (sl)
JP (1) JP2002523415A (sl)
KR (1) KR20010072798A (sl)
CN (1) CN1329613A (sl)
AR (1) AR020226A1 (sl)
AT (1) ATE280768T1 (sl)
AU (1) AU5767999A (sl)
BR (1) BR9913103A (sl)
CA (1) CA2339286A1 (sl)
DE (1) DE69921483T2 (sl)
DK (1) DK1105391T3 (sl)
ES (1) ES2229763T3 (sl)
IL (1) IL141166A0 (sl)
NO (1) NO20010860L (sl)
PT (1) PT1105391E (sl)
SE (1) SE9802794D0 (sl)
SI (1) SI1105391T1 (sl)
WO (1) WO2000011000A2 (sl)
ZA (1) ZA200100913B (sl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
SE0102808D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
CN100549011C (zh) * 2002-09-19 2009-10-14 先灵公司 用作细胞周期蛋白依赖性激酶抑制剂的新颖咪唑并吡啶
MY136840A (en) * 2002-09-19 2008-11-28 Schering Corp Pyrazolopyridines as cyclin dependent kinase inhibitors
PT1606261E (pt) 2003-03-10 2010-01-11 Nycomed Gmbh Novo processo para a preparação de roflumilast
SE0301904D0 (sv) 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
US8536492B2 (en) * 2003-10-27 2013-09-17 Applied Materials, Inc. Processing multilayer semiconductors with multiple heat sources
CN101361738A (zh) 2003-11-03 2009-02-11 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2-a]吡啶衍生物
EP1711498A2 (en) * 2004-01-26 2006-10-18 Altana Pharma AG 1,2,4-triazolo¬1,5-a|pyridines as gastric acid secretion inhibitors
KR20200105967A (ko) * 2004-07-28 2020-09-09 다케다 야쿠힌 고교 가부시키가이샤 피롤로〔2,3-ｃ〕피리딘 화합물, 그 제조 방법 및 용도
EP1861074B1 (en) * 2005-03-16 2013-04-24 Takeda GmbH Taste masked dosage form containing roflumilast
WO2008065199A1 (en) * 2006-12-01 2008-06-05 Galapagos N.V. Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases
US20100267712A1 (en) * 2007-09-27 2010-10-21 The United States of America, as represented by the Secretary, Department of Health and Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
BRPI1013288A2 (pt) 2009-07-09 2016-03-29 Raqualia Pharma Inc uso de um composto, método de composição farmacêutica para o tratamento de doenças em que a motilidade gastrointestinal anormal está envolvida, kit e embalagem comercial que compreende uma composição farmacêutica contendo o composto
CN111606846A (zh) * 2020-05-12 2020-09-01 广州理文科技有限公司 一种n`-三氟甲磺酰基n杂芳香胺类化合物及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
EP0068378B1 (en) * 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
US5574042A (en) 1992-11-02 1996-11-12 Fujisawa Pharmaceutical Co., Ltd Imidazo [1,2-a] pyridines and their pharmaceutical use
IL108520A (en) 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ES2167362T3 (es) 1993-04-22 2002-05-16 Byk Gulden Lomberg Chem Fab Sales de piridinio y su utilizacion para combatir a bacterias helicobacter.
UA48122C2 (uk) 1993-10-11 2002-08-15 Бік Гульден Ломберг Хеміше Фабрік Гмбх АЛКОКСІАЛКІЛКАРБАМАТИ ІМІДАЗО[1,2-а]ПІРИДИНІВ, СПОСІБ ЇХ ОДЕРЖАННЯ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
EP0772614A1 (de) * 1994-07-28 1997-05-14 Byk Gulden Lomberg Chemische Fabrik GmbH Halogenimidazopyridine
EP0773945A1 (de) 1994-07-28 1997-05-21 Byk Gulden Lomberg Chemische Fabrik GmbH Acylimidazopyridine
AU700737B2 (en) * 1994-07-28 1999-01-14 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzylimidazopyridines
CN1046726C (zh) * 1994-07-28 1999-11-24 比克·古尔顿·劳姆贝尔格化学公司 咪唑并吡啶－吡咯烷酮、其制法和药用
DE19602853A1 (de) * 1996-01-26 1997-07-31 Byk Gulden Lomberg Chem Fab Neue Halogenimidazopyridine
US6096758A (en) 1996-01-26 2000-08-01 Byk Gulden Lomberg Chemische Fabrik Gmbh 3-methylimidazopyridines
SE9700661D0 (sv) * 1997-02-25 1997-02-25 Astra Ab New compounds
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
SE9802793D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds

Also Published As

Publication number Publication date
NO20010860D0 (no) 2001-02-20
WO2000011000A2 (en) 2000-03-02
EP1105391B1 (en) 2004-10-27
BR9913103A (pt) 2001-05-08
NO20010860L (no) 2001-04-23
AU5767999A (en) 2000-03-14
PT1105391E (pt) 2005-01-31
CN1329613A (zh) 2002-01-02
EP1411056A2 (en) 2004-04-21
SE9802794D0 (sv) 1998-08-21
CA2339286A1 (en) 2000-03-02
JP2002523415A (ja) 2002-07-30
EP1105391A2 (en) 2001-06-13
ZA200100913B (en) 2002-05-02
US6579884B1 (en) 2003-06-17
ES2229763T3 (es) 2005-04-16
US20030220364A1 (en) 2003-11-27
US6790960B2 (en) 2004-09-14
DE69921483D1 (de) 2004-12-02
AR020226A1 (es) 2002-05-02
ATE280768T1 (de) 2004-11-15
DK1105391T3 (da) 2005-01-24
WO2000011000A3 (en) 2000-06-15
DE69921483T2 (de) 2006-02-02
US20050154007A1 (en) 2005-07-14
EP1411056A3 (en) 2004-04-28
KR20010072798A (ko) 2001-07-31
IL141166A0 (en) 2002-02-10

Similar Documents

Publication Publication Date Title
SI1105391T1 (sl) Imidazo(1,2-a)piridinske spojine, ki inhibirajo izločanje želodčne kisline, njihovi farmacevtski sestavki in postopki za njihovo pripravo
HUP0102425A3 (en) Imidazo pyridine derivatives which inhibit gastric acid secretion, process for producing them and pharmaceutical compositions containing them
IL136145A0 (en) Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
HUP0200450A3 (en) Cephen derivatives containing an imidazo[4,5-b]pyridiniummethyl moiety, process for their preparation and pharmaceutical compositions of the same
AU7922900A (en) Thiazole and imidazo (4,5-b) pyridine compounds and their pharmaceutical use
HUT72448A (en) O-, n- ors-containing heterobicyclic compounds, pharmaceutical compositions comprising them and process for their preparation
HUP0201376A2 (en) Thiazoloderivatives and pharmaceutical compositions containing them and process for preparation the compounds
HUP0303148A3 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, pharmaceutical compositions containing the compounds and processes for their preparation
IL131415A (en) Anti-inflammatory compounds, processes for their preparation and pharmaceutical compositions comprising them
HUP0401292A3 (en) Pyrazolo[1,5-a]pyridines, pharmaceutical compositions containing the same and process for preparation thereof
HUP0105054A3 (en) Imidazo[4,5-c]-pyridine-4-on-derivatives, pharmaceutical compositions containing them and process for their preparation
IL113263A0 (en) Imidazo pyridine compounds and pharmaceutical compositions for the treatment of gastrointestinal diseases
HUP0102117A2 (hu) Imidazo[1,2-a]piridin-származékok és ezeket tartalmazó gyógyászati készítmények
HU9302741D0 (en) Gastric acid secretion inhibiting new pyrrolo[2,3-b]pyridine derivatives
HK1036274A1 (en) Imidazo (1,2-a) pyridine derivatives for the treatment of gastrointestinal diseases
IL190120A0 (en) PREPARATION OF 9-AMINO OCTAHYDRO-6,10-DIOXO-6H-PYRIDAZINO/1,2-a//1,2/DIAZEPIN-1-CARBOXYLIC ACID DERIVATIVES
EP0499416A3 (en) Pyridine compounds as angiotensin ii antagonists, processes for their preparation and pharmaceutical compositions containing them
NZ224032A (en) Imidazo(1,2-a)pyridine derivatives and pharmaceutical compositions
SI1275647T1 (sl) Derivati oktahidro-2h-pirido/1,2-a/pirazina, postopek za njihovo pripravo in farmacevtski pripravki, ki jih vsebujejo
IL157461A0 (en) Use of carboxamido imidazo [1,2] pyridine deivatives in the preparation of medicaments for treating or preventing gastric ulcer
HUP9801894A3 (en) Use of dofetilide for the preparation of pharmaceutical compositions treating congestive heart failure
IL82532A0 (en) Pyrazolo(3,4-b)pyridine derivatives,processes for the preparation thereof and herbicidal compositions containing the same
SI1073657T1 (sl) Imidazo piridinski derivati, ki inhibirajo izlocanje zelodcne kisline
HUP0201321A3 (en) New betha-amide and betha-sulfonamide carboxylic acid derivatives, their preparation and pharmaceutical compositions containing the compounds
SI1105390T1 (sl) Derivati imidazo/1,2-a/piridina za zdravljenje gastrointestinalnih bolezni